©Author(s) (or their employer(s)) 2026.
World J Psychiatry. Mar 19, 2026; 16(3): 115163
Published online Mar 19, 2026. doi: 10.5498/wjp.v16.i3.115163
Published online Mar 19, 2026. doi: 10.5498/wjp.v16.i3.115163
Table 2 Statistical summary of serum cytokine concentrations for healthy controls and patients both before and after electroconvulsive therapy, mean ± SD
| Healthy controls (n = 55) | Patients (n = 77) | P value | ||||
| Before ECT | After ECT | Within-group comparison1 | Before ECT vs healthy controls2 | After ECT vs healthy controls2 | ||
| Tumor necrosis factor-alpha (pg/mL) | 3.77 ± 1.55 | 5.72 ± 2.31 | 6.19 ± 2.07 | 0.071 | < 0.001 | < 0.001 |
| Log IL-8 (pg/mL) | 0.82 ± 0.17 | 1.26 ± 0.31 | 1.41 ± 0.31 | 0.002 | < 0.001 | < 0.001 |
| Log IL-18 (pg/mL) | 2.44 ± 0.21 | 2.10 ± 0.19 | 2.17 ± 0.18 | < 0.001 | < 0.001 | < 0.001 |
- Citation: Xu L, Zhang XB, Luan LS, Yang M, Zhang J, Yang HD, Tang XW. Electroconvulsive therapy alters serum cytokine levels and correlates with symptom improvement in patients with acute schizophrenia. World J Psychiatry 2026; 16(3): 115163
- URL: https://www.wjgnet.com/2220-3206/full/v16/i3/115163.htm
- DOI: https://dx.doi.org/10.5498/wjp.v16.i3.115163